Gastric Cancer

, Volume 22, Issue 4, pp 864–872 | Cite as

Impact of preoperative wait time on survival in patients with clinical stage II/III gastric cancer

  • Kenichiro Furukawa
  • Tomoyuki Irino
  • Rie Makuuchi
  • Yusuke Koseki
  • Kenichi Nakamura
  • Yuhei Waki
  • Keiichi Fujiya
  • Hayato Omori
  • Yutaka Tanizawa
  • Etsuro Bando
  • Taiichi Kawamura
  • Masanori TerashimaEmail author
Original Article



Preoperative wait time is affected by various factors, and a certain time is needed before surgery. There is a concern that cancer treatment delay can lead to poor survival. The present study aimed to evaluate the impact of preoperative wait time on survival in patients with clinical stage (cStage) II/III gastric cancer.


The study included patients with cStage II/III primary gastric cancer undergoing surgery between 2002 and 2012. Preoperative wait time was defined as the time from endoscopy for initial diagnosis to surgery. Patients were divided into the following three groups according to wait time: short wait group (≤ 30 days), intermediate wait group (> 30 and ≤ 60 days), and long wait group (> 60 and ≤ 90 days). Patient characteristics and survival were compared among the groups.


This study included 467 male (67%) and 229 female (33%) patients, and the median patient age was 67 years. The numbers of cStage II and III patients were 332 (48%) and 364 (52%), respectively. The median wait time was 45 days. The body mass index was lower in the short wait group than in the other groups. A shorter wait time tended to be associated with a more advanced cStage. Although survival was significantly worse in the short wait group than in the long wait group, wait time was not identified as an independent prognostic factor in multivariate analysis.


Preoperative wait time up to 90 days does not affect survival in patients with cStage II/III gastric cancer.


Gastric cancer Preoperative wait time Surgery Survival 



This study was funded by National Cancer Center Research and Development Fund (29-4-3).

Compliance with ethical standards

Ethical standards

All procedures followed were in accordance with the ethical standards of responsible committees on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or an appropriate substitute was obtained.

Conflict of interest

Author MT has received research grants from Taiho Pharmaceutical Co. Ltd., Chugai Pharmaceutical company, Eli Lilly Japan, Ono Pharmaceutical company, Bristol Myers Squib Japan, and Yakult Honsha Co., Ltd. Author EB has received research grants from EIZO Corporation, Kanehara-Shuppan, TERUMO CORPORATION, and EIZAI.

Supplementary material

10120_2018_910_MOESM1_ESM.docx (15 kb)
Supplementary material 1 (DOCX 15 KB)


  1. 1.
  2. 2.
    Visser E, Leeftink AG, van Rossum PS, Siesling S, van Hillegersberg R, Ruurda JP. Waiting time from diagnosis to treatment has no impact on survival in patients with esophageal cancer. Ann Surg Oncol. 2016;23:2679–89.CrossRefGoogle Scholar
  3. 3.
    Bilimoria KY, Ko CY, Tomlinson JS, Stewart AK, Talamonti MS, Hynes DL, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253:779–85.CrossRefGoogle Scholar
  4. 4.
    Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2:330–9.CrossRefGoogle Scholar
  5. 5.
    Eriksson L, Bergh J, Humphreys K, Warnberg F, Tornberg S, Czene K. Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: a population-based cohort study. Int J Cancer. 2018;143:1093–104.CrossRefGoogle Scholar
  6. 6.
    Yun YH, Kim YA, Min YH, Park S, Won YJ, Kim DY, et al. The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol. 2012;23:2731–7.CrossRefGoogle Scholar
  7. 7.
    Shin DW, Cho J, Kim SY, Guallar E, Hwang SS, Cho B, et al. Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol. 2013;20:2468–76.CrossRefGoogle Scholar
  8. 8.
    Miki Y, Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Terashima M. Staging laparoscopy for patients with cM0, Type 4, and large Type 3 gastric cancer. World J Surg. 2015;39:2742–7.CrossRefGoogle Scholar
  9. 9.
    Irino T, Sano T, Hiki N, Ohashi M, Nunobe S, Kumagai K, et al. Diagnostic staging laparoscopy in gastric cancer: a prospective cohort at a cancer institute in Japan. Surg Endosc. 2018;32:268–75.CrossRefGoogle Scholar
  10. 10.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefGoogle Scholar
  11. 11.
    Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRefGoogle Scholar
  12. 12.
    Bando E, Makuuchi R, Tokunaga M, Tanizawa Y, Kawamura T, Terashima M. Impact of clinical tumor-node-metastasis staging on survival in gastric carcinoma patients receiving surgery. Gastric Cancer. 2017;20:448–56.CrossRefGoogle Scholar
  13. 13.
    Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRefGoogle Scholar
  14. 14.
    Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.CrossRefGoogle Scholar
  15. 15.
    Feng F, Zheng G, Guo X, Liu Z, Xu G, Wang F, et al. Impact of body mass index on surgical outcomes of gastric cancer. BMC Cancer. 2018;18:151.CrossRefGoogle Scholar
  16. 16.
    Crawford SC, Davis JA, Siddiqui NA, de Caestecker L, Gillis CR, Hole D, et al. The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ. 2002;325:196.CrossRefGoogle Scholar
  17. 17.
    Kotz BS, Croft S, Ferry DR. Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? A study based on West Midlands cancer registration data. Br J Cancer. 2006;95:835–40.CrossRefGoogle Scholar
  18. 18.
    Matsuo K, Opper NR, Ciccone MA, Garcia J, Tierney KE, Baba T, et al. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome. Obstet Gynecol. 2015;125:424–33.CrossRefGoogle Scholar
  19. 19.
    Diaconescu R, Lafond C, Whittom R. Treatment delays in non-small cell lung cancer and their prognostic implications. J Thorac Oncol. 2011;6:1254–9.CrossRefGoogle Scholar
  20. 20.
    Korets R, Seager CM, Pitman MS, Hruby GW, Benson MC, McKiernan JM. Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis. BJU Int. 2012;110:211–6.CrossRefGoogle Scholar
  21. 21.
    Gulliford MC, Petruckevitch A, Burney PG. Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment. BMJ. 1991;303:437–40.CrossRefGoogle Scholar
  22. 22.
    Umezu T, Shibata K, Kajiyama H, Yamamoto E, Mizuno M, Kikkawa F. Prognostic factors in stage IA-IIA cervical cancer patients treated surgically: does the waiting time to the operation affect survival? Arch Gynecol Obstet. 2012;285:493–7.CrossRefGoogle Scholar
  23. 23.
    Roland CL, Schwarz RE, Tong L, Ahn C, Balch GC, Yopp AC, et al. Is timing to delivery of treatment a reliable measure of quality of care for patients with colorectal adenocarcinoma? Surgery. 2013;154:421–8.CrossRefGoogle Scholar
  24. 24.
    Kim SJ, Kim HH, Kim YH, Hwang SH, Lee HS, Park DJ, et al. Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer. Radiology. 2009;253:407–15.CrossRefGoogle Scholar
  25. 25.
    Gray RE, Fitch MI, Phillips C, Labrecque M, Klotz L. Presurgery experiences of prostate cancer patients and their spouses. Cancer Pract. 1999;7:130–5.CrossRefGoogle Scholar
  26. 26.
    Robinson KM, Christensen KB, Ottesen B, Krasnik A. Diagnostic delay, quality of life and patient satisfaction among women diagnosed with endometrial or ovarian cancer: a nationwide Danish study. Qual Life Res. 2012;21:1519–25.CrossRefGoogle Scholar
  27. 27.
    Song H, Fang F, Valdimarsdottir U, Lu D, Andersson TM, Hultman C, et al. Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study. BMC Cancer. 2017;17:2.CrossRefGoogle Scholar

Copyright information

© The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2018

Authors and Affiliations

  • Kenichiro Furukawa
    • 1
  • Tomoyuki Irino
    • 1
  • Rie Makuuchi
    • 1
  • Yusuke Koseki
    • 1
  • Kenichi Nakamura
    • 1
  • Yuhei Waki
    • 1
  • Keiichi Fujiya
    • 1
  • Hayato Omori
    • 1
  • Yutaka Tanizawa
    • 1
  • Etsuro Bando
    • 1
  • Taiichi Kawamura
    • 1
  • Masanori Terashima
    • 1
    Email author
  1. 1.Division of Gastric SurgeryShizuoka Cancer CenterShizuokaJapan

Personalised recommendations